Nascent Pharma Holdings, Inc. (NASC) Financials
Stock symbol NASC is outdated, potentially delisted? Maybe it is available on other exchange?
NASC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 1.9 million | 11.6 million |
| June 30, 2024 | 4.9 million | 11.1 million |
| March 31, 2024 | 5.3 million | 10.4 million |
| Dec. 31, 2023 | 10.1 million | 11.1 million |
NASC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | 9098 | ? |
| June 30, 2024 | -130920 | ? |
| March 31, 2024 | 216995 | 1.2 million |
| Dec. 31, 2023 | 151438 | 128500 |
NASC Net Income
No data available :(
NASC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 7879 | - | - |
| June 30, 2024 | - | - | 65771 |
| March 31, 2024 | 26582 | - | 150679 |
| Dec. 31, 2023 | 34006 | - | 254391 |
NASC Shares Outstanding
NASC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | - | - | 2.4 million | - |
| June 30, 2024 | - | - | 1.2 million | - |
| March 31, 2024 | - | - | 3.7 million | - |
| Dec. 31, 2023 | - | - | 1.6 million | -248779 |
NASC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 15269 | 415816 |
| June 30, 2024 | 272287 | 665471 |
| March 31, 2024 | 369096 | 1.2 million |
| Dec. 31, 2023 | 376889 | 350034 |
NASC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NASC
Price: $0.01
52 week price:
Earnings Per Share: 0.09 USD
P/E Ratio: 0.13
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 million